Dermatology Times 2025 Year in Review: Strides for Skin Health Equity
Late-breaking trial data offered encouraging signs of progress. Subgroup analyses demonstrated that targeted therapies, including biologics and JAK inhibitors, can...
Late-breaking trial data offered encouraging signs of progress. Subgroup analyses demonstrated that targeted therapies, including biologics and JAK inhibitors, can...
Recent research from the University of Innsbruck has provided new insights into how social media influences patient skin care behaviors...